<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Peripherally inserted central catheter (PICC)-related venous thrombosis in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Peripherally inserted central catheter (PICC)-related venous thrombosis in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Peripherally inserted central catheter (PICC)-related venous thrombosis in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vineet Chopra, MD, MSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ingemar Davidson, MD, PhD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3365935718"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Owing to ease of insertion through peripheral veins of the upper extremity, peripherally inserted central catheter (PICC) use has become increasingly popular. Although the insertion route of PICCs avoids complications such as pneumothorax or injury to the vessels of the neck and chest, PICCs are associated with important complications [<a href="#rid1">1</a>]. Principal among these is an increased risk of deep vein thrombosis (DVT) [<a href="#rid2">2,3</a>]. Some estimates suggest that PICCs are responsible for over one-third of all upper extremity DVTs [<a href="#rid4">4</a>], suggesting that the arm veins are perhaps the most thrombotic sites in which a central venous catheter can be placed [<a href="#rid5">5</a>]. </p><p>Upper extremity venous thrombosis related to PICCs is reviewed here. An overview of upper extremity catheter-related venous thrombosis is provided separately. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults"</a>.)</p><p class="headingAnchor" id="H3789690266"><span class="h1">INCIDENCE AND RISK FACTORS</span><span class="headingEndMark"> — </span>Even when used for short-term (days) or medium-term (weeks) treatment, PICCs carry a substantial risk of thrombosis that should be carefully considered prior to use [<a href="#rid6">6-8</a>]. PICCs appear to be associated with a greater risk for venous thrombosis overall (superficial and deep thrombosis) compared with centrally inserted catheters (CICCs; including ports), particularly in those who are critically ill or who have malignancy [<a href="#rid4">4,7-18</a>]. The incidence of deep vein thrombosis (DVT) for PICCs is between 5 and 15 percent for hospitalized patients and 2 and 5 percent for ambulatory patients [<a href="#rid12">12,19,20</a>]. Studies that screen for PICC-related DVT using weekly surveillance, regardless of the presence of symptoms, report rates of DVT as high as 33 percent [<a href="#rid14">14</a>]. </p><p>A systematic review that included 64 studies found that PICCs were associated with a stepwise increase in the prevalence of DVT based on patient population [<a href="#rid14">14</a>]. As an example, the prevalence of PICC-related DVT in studies including hospitalized patients was 3 percent and was 6 percent in patients with cancer. Studies of critically ill patients with PICCs had the highest risk of PICC-related DVT, with a prevalence of 13 percent. Among 12 studies that directly compared risk of thrombosis of PICCs with central venous catheters (CVCs) placed in the internal jugular and subclavian vein, PICCs were associated with a 2.5-fold greater risk of thrombosis. </p><p>The Medical Inpatients and Thrombosis (MITH) Study was a case-cohort study in which all cases of venous thromboembolism at a single institution from 2000 to 2009 were matched 1:2 with patients who did not have venous thromboembolism [<a href="#rid8">8</a>]. In this study, central catheter use was associated with a 14-fold increased risk for upper extremity DVT, without a significantly increased risk for pulmonary embolism. PICCs were associated with a higher risk compared with CICCs. The cumulative incidences for upper extremity DVTs were 0.2, 4.8, and 8.1 per 1000 admissions for no central venous catheters, CICCs, and PICCs, respectively. </p><p>Later studies examining PICC insertion using "modern" insertion techniques such as ultrasound-guided insertion, micro-introducers, and ECG guidance suggest that when these are used, the risk of PICC-related DVT may be lower than previously reported. In a systematic review of 15 studies published after 2010, the overall rate of PICC-related DVT was 2.4 percent (95% CI 1.5 to 3.3 percent) [<a href="#rid21">21</a>]. However, the incidence remained high in studies of hematology and oncology patients at 5.9 percent (95% CI 1.2 to 10.0 percent). Importantly, there was considerable heterogeneity of the included populations (I<sup>2</sup> = 75 percent), and bias related to loss to follow-up among the included studies was reported. </p><p class="headingAnchor" id="H4252981627"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors associated with PICC thrombosis can be categorized as patient-, provider-, and device-related factors [<a href="#rid22">22</a>]. The best way to prevent DVT is to avoid a device unless absolutely necessary. Choosing an appropriate device is therefore paramount in preventing PICC-related thrombosis. (See <a class="local">'Prevention'</a> below and  <a class="medical medical_review" href="/z/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults"</a>.)</p><p class="headingAnchor" id="H2247835029"><span class="h3">Patient factors</span><span class="headingEndMark"> — </span>Among patient factors, prior history of DVT (especially if such an event occurred within 30 days), obesity, hematological malignancies, critical illness, and comorbidities such as diabetes and obstructive lung disease have been linked to PICC-related DVT [<a href="#rid9">9,10,23-29</a>]. Cancer, in particular, remains an important patient subset in which use of PICCs is associated with significant risk of DVT [<a href="#rid30">30-32</a>]. As an example, in a review of over 3000 patients with solid cancers, catheter occlusion occurred in 10 percent of patients, and DVT occurred in 3.6 percent. (See  <a class="medical medical_review" href="/z/d/html/1361.html" rel="external">"Overview of the causes of venous thrombosis"</a> and  <a class="medical medical_review" href="/z/d/html/17036.html" rel="external">"Overview of thoracic central venous obstruction"</a>.)</p><p class="headingAnchor" id="H1837343336"><span class="h3">Device factors</span><span class="headingEndMark"> — </span>The device factors most associated with PICC-related DVT include the size of the catheter, which, in turn, is related to the number of catheter lumens, and catheter tip location. As with centrally inserted catheters, the incidence of PICC-related DVT increases with increasing number of lumens [<a href="#rid10">10,15,24</a>] and for left-sided catheters [<a href="#rid33">33</a>]. Another risk factor is exchange of PICCs over a guidewire, which may be done if a PICC tip has been malpositioned or if the catheter becomes dislodged [<a href="#rid34">34</a>].</p><p>PICCs traverse a greater length of vein, and, although the catheter is small relative to the central veins, the catheter may occupy the entire internal diameter of the peripheral vein into which it is inserted [<a href="#rid9">9</a>]. The increase in thrombogenicity of PICCs is explained, in part, by their insertion route; PICCs are placed into the smaller, peripheral veins of the upper extremity, typically in the arm (eg, brachial vein, basilic vein), where they occupy a greater fraction of the cross-sectional area of the vein. This property (termed the catheter-to-vein ratio) is a key factor associated with PICC-related DVT [<a href="#rid14">14</a>]. Add to this the endothelial injury associated with PICC insertion and the hypercoagulable profile of hospitalized patients who often receive this device, and PICCs easily satisfy Virchow's triad. A prospective cohort study suggested that the optimal catheter-to-vein ratio is &lt;45 percent; that is, the catheter should not occupy more than 45 percent of the vessel diameter; PICCs that did not respect this rule were associated with a 13-fold greater risk of thrombosis [<a href="#rid35">35</a>]. Later studies suggest that in certain patient groups, ensuring a smaller catheter-to-vein ratio by using the smallest caliber catheter possible for the visualized vein diameter may be more important [<a href="#rid36">36</a>]. Thus, observance of the catheter-to-vein ratio is an important provider-dependent factor associated with thrombosis [<a href="#rid37">37</a>]. The brachial and basilic veins provide a large cross-sectional area for placing a PICC [<a href="#rid38">38</a>]. Alternatively, puncture of veins that are more proximal (eg, the axillary vein in the deltopectoral groove) provides access to larger-caliber vessels and results in lower rates of DVT [<a href="#rid39">39</a>]. </p><p>In general, the greater the number of PICC lumens, the greater the size of the catheter and resultant vein size that is necessary. The larger diameter of double- or triple-lumen catheters occupies a greater cross-sectional area of the smaller peripheral (compared with axillosubclavian) vein, leading to more stasis. A prospective study evaluating outcomes for triple-lumen PICCs was terminated prematurely after venous thrombosis was identified in 58 percent of the patients. Only 20 percent of these patients were symptomatic, and 10 percent involved the deep veins [<a href="#rid40">40</a>]. In another prospective study evaluating 2014 PICC placements, the incidence of symptomatic DVT was 3 percent [<a href="#rid10">10</a>]. </p><p>Using the least number of lumens and catheter size to meet clinical needs is thus advised by most guidelines [<a href="#rid41">41,42</a>] and has been shown to prevent complications in a number of clinical settings [<a href="#rid43">43-46</a>]. In response to this issue, manufacturers are designing newer-generation PICCs that provide more lumens with less cross-sectional diameter. </p><p class="headingAnchor" id="H1383521569"><span class="h3">Provider factors</span><span class="headingEndMark"> — </span>Appropriate patient selection, proper placement, and positioning are key provider components that contribute to the incidence of PICC-related DVT. The use of ultrasound for PICC placement, a practice that is associated with fewer attempts to placement, is associated with lower rates of PICC-related DVT, lower rates of phlebitis, and lower rates of thrombosis [<a href="#rid47">47,48</a>]. (See  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access"</a> and  <a class="medical medical_review" href="/z/d/html/8194.html" rel="external">"Central venous access in adults: General principles", section on 'Use of ultrasound'</a>.)</p><p>Catheter tip location is another important device factor. PICC tips should reside at the cavoatrial junction (CAJ) or the right atrium (RA), where blood flow is greatest and risk of DVT is lowest [<a href="#rid49">49,50</a>]. PICCs that do not terminate in this location (ie, those in the middle to proximal third of the superior vena cava) are associated with sevenfold greater rates of DVT [<a href="#rid51">51</a>]. Similarly, power injection of contrast dye may promulgate tip malposition, which is important to consider when using PICCs for radiographic studies [<a href="#rid52">52,53</a>]. Placement methods that ensure proper PICC tip positioning may reduce the incidence of DVT. (See  <a class="medical medical_review" href="/z/d/html/8194.html" rel="external">"Central venous access in adults: General principles", section on 'Confirming catheter tip position'</a>.)</p><p>Placement of PICCs using electrocardiographic technology (a technique that localizes the PICC tip to the sinoatrial node that resides close to the CAJ/RA) is an advance that helps assure optimal tip position [<a href="#rid54">54,55</a>]. In a secondary analysis of a prospective registry, the overall incidence of DVT among 42,687 patients with PICCs was 1.3 percent [<a href="#rid56">56</a>]. About half of PICCs were confirmed radiographically, and the other half were confirmed using electrocardiography. Following adjustment for other DVT risk factors (eg, larger catheter size, history of DVT, cancer), electrocardiographic guidance was associated with a lower risk of PICC-related DVT compared with radiographic imaging (odds ratio 0.74, 95% CI, 0.58-0.93). These findings suggest that electrocardiographic guidance may not only provide benefits related to radiographic exposure, but also safety with respect to thrombosis.</p><p class="headingAnchor" id="H408047343"><span class="h2">Risk prediction</span><span class="headingEndMark"> — </span>Several investigators have sought to predict and stratify risk of upper extremity DVT associated with central venous catheters, and PICCs specifically. </p><p class="bulletIndent1"><span class="glyph">●</span>One tool to predict the risk of upper extremity DVT assigns points to each of the following risk factors: presence of any intravenous device, localized pain, unilateral edema, or alternative plausible cause for symptoms [<a href="#rid57">57</a>]. Although useful, this tool was not PICC specific and often placed patients in an intermediate risk category. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another model to predict DVT was developed using available data on patient, provider, and device factors from 1728 patients who received PICCs [<a href="#rid10">10</a>]. The best-performing model for DVT (area under the curve, 0.83) included prior DVT (odds ratio [OR] 9.92, 95% CI 5.08-21.25), use of double-lumen 5-French (Fr; OR 7.54, 95% CI 1.61-100+) or triple-lumen 6-Fr (OR 19.50, 95% CI 3.54-100+) PICCs, and surgery lasting &gt;60 minutes while the PICC was in place (OR 1.66, 95% CI 0.91-3.01). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Michigan Risk Score (MRS (<a class="calc calc_professional" href="/z/d/html/130330.html" rel="external">calculator 1</a>)) is a model based on data from over 20,000 patients. Risk factors associated with PICC-related DVT included history of previous DVT, placement of a multilumen PICC, active cancer, presence of another central venous catheter when the PICC was placed, and white blood cell count greater than 12,000 [<a href="#rid24">24</a>]. Four risk classes were created based on thrombosis risk. Thrombosis rates were 0.9 percent for class I, 1.6 percent for class II, 2.7 percent for class III, and 4.7 percent for class IV. Validation studies of the MRS suggest that its performance may vary across patient populations [<a href="#rid58">58,59</a>].</p><p></p><p class="headingAnchor" id="H1934558853"><span class="h1">CLINICAL FEATURES AND DIAGNOSIS</span><span class="headingEndMark"> — </span>Most events occur within the first 7 to 14 days of catheter insertion (ie, dwell time) and accumulate as catheter dwell times increases [<a href="#rid27">27</a>]. Catheter-related thromboses (PICCs and centrally inserted venous catheters alike) typically remain clinically silent [<a href="#rid60">60</a>]. It is estimated that only 3 to 10 percent of patients with PICC-related deep vein thrombosis (DVT) exhibit symptoms. Thus, a diagnosis of PICC-related thrombosis should be guided by clinical suspicion, which in turn may be assessed through risk prediction models. (See <a class="local">'Risk prediction'</a> above.). </p><p>Most PICC-related DVT does not occur at the site of insertion but in the deep veins of the upper extremity, typically at the junction of the axillary and subclavian veins. When symptomatic, the patient often complains of arm or forearm pain or swelling [<a href="#rid12">12</a>]. Measurement of limb circumference (which should be documented at baseline when a PICC is placed) is an objective and helpful way to assess an increase in girth [<a href="#rid61">61</a>]. As thrombosis progresses, dilation of the veins of the upper extremity, chest, and neck may result as collaterals develop to bypass the obstruction. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/z/d/html/131420.html" rel="external">"Clinical features, diagnosis, and classification of thoracic central venous obstruction"</a>.)</p><p>Superficial vein thrombosis (redness, pain, and swelling over the site of skin puncture and catheter entry) was a common occurrence among older-generation PICCs that were made of silicone [<a href="#rid62">62,63</a>] and inserted without ultrasound guidance. It is less common with newer polyurethane devices placed using ultrasound guidance. </p><p>Pulmonary embolism (PE) is rare with PICC-related DVT. However, PICC use has been linked to development of lower extremity thrombosis and may increase the risk of PE from this location [<a href="#rid18">18</a>]. The precise mechanism by how PICCs are linked to lower extremity DVT is unclear, but the fact that lower extremity clots are more often symptomatic and easier to detect (ie, ascertainment bias) may play a role.</p><p>Complete or partial occlusion or difficulty infusing or aspirating from the PICC may be associated with but is not necessarily a sign of PICC-related venous thrombosis. Intraluminal precipitation of drugs or minerals, blood products, or kinking of the catheter from extraluminal causes can create this clinical picture. Furthermore, formation of fibrin tails or sheaths (thin, slender structures that wrap around the catheter or the distal end of the device) can also lead to catheter dysfunction. The term catheter-related venous thrombosis should be reserved for radiographic evidence of thrombosis involving the vein in which a catheter resides. </p><p class="headingAnchor" id="H365800577"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>As is the case with most DVT, diagnosis of PICC-related DVT is best made by compression ultrasonography or duplex- or Doppler-enhanced ultrasound for upper extremity thromboses [<a href="#rid64">64</a>]. Visible thrombus in the vein in which a catheter resides, absence of compressibility, or reversal of blood flow are commonly reported radiographic findings in the setting of PICC-related DVT. A systematic review of 793 patients reported a sensitivity and specificity of compression ultrasound of 97 and 96 percent, respectively [<a href="#rid65">65</a>]. However, the performance drops significantly for central thromboses involving the subclavian or chest veins when anatomic structures and vessel depth limit compression and visualization. If suspicion for DVT remains high in spite of negative ultrasound, additional testing is recommended using venography (computed tomography, catheter based) with or without use of highly sensitive D-dimer [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Diagnostic evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/131420.html" rel="external">"Clinical features, diagnosis, and classification of thoracic central venous obstruction"</a>.)</p><p class="headingAnchor" id="H2020272117"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of PICC-related thrombosis includes symptomatic care, anticoagulation, and possibly thrombolysis. Symptomatic care includes extremity elevation, warm or cold compresses, and oral nonsteroidal anti-inflammatory agents (NSAIDs). Whether to remove the catheter depends upon whether it is functional and necessary. Replacement of the PICC must weigh the increased risk for venous thrombosis at the site of the newly placed catheter [<a href="#rid24">24,27</a>]. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Superficial vein thrombosis and phlebitis'</a>.)</p><p class="headingAnchor" id="H1786079554"><span class="h2">Anticoagulation</span><span class="headingEndMark"> — </span>Guidelines for the treatment of venous thromboembolism disease recommend at least three months of uninterrupted systemic anticoagulation for catheter-related upper extremity DVT (including PICC-related DVT) involving deep veins of the upper extremity (eg, brachial veins, axillary veins) or chest (eg, subclavian vein, other great vessels) [<a href="#rid66">66-68</a>]. The type and intensity of anticoagulant therapy with catheter-related upper extremity DVT is similar to that given to prevent embolization from lower extremity DVT. While both <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> and low-molecular-weight heparin (LMWH) may be used, LMWH is preferred in patients with catheter-related DVT who are pregnant or those with cancer [<a href="#rid69">69</a>]. Alternative agents may be needed in those who cannot take heparin. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Anticoagulation'</a> and  <a class="medical medical_review" href="/z/d/html/17036.html" rel="external">"Overview of thoracic central venous obstruction", section on 'Anticoagulation'</a>.)</p><p>Although there are no specific recommendations regarding direct oral anticoagulants (DOACs) for catheter-related upper extremity DVT, one study reported faster resolution of PICC-related DVT with low rates of bleeding in those treated with <a class="drug drug_general" data-topicid="9498" href="/z/d/drug information/9498.html" rel="external">rivaroxaban</a> compared with traditional agents [<a href="#rid70">70</a>]. Several studies are ongoing examining the role of DOACs in catheter-related DVT [<a href="#rid31">31</a>]. In addition, cancer-related guidelines and recommendations are evolving to more frequently recommend DOACs in patients with malignancy-related thrombosis [<a href="#rid67">67,68,71-73</a>].</p><p>Anticoagulation should be continued for as long as the PICC remains in place [<a href="#rid67">67,68,74,75</a>]. However, data supporting this recommendation are scant and largely extrapolated from retrospective cohort studies and trials involving lower extremity DVT. (See <a class="local">'Handling the catheter'</a> below.)</p><p class="headingAnchor" id="H1686087423"><span class="h2">Thrombolysis</span><span class="headingEndMark"> — </span>Interventional techniques may also be used to treat PICC-related DVT, especially if the burden of thrombosis is large or if there is concern for phlegmasia. Thrombolysis can be considered for patients who meet the following criteria: severe symptoms that do not improve with anticoagulation, thrombosis spanning both the subclavian and axillary veins, good performance status, symptoms &lt;14 days, life expectancy &gt;1 year, and low risk for bleeding [<a href="#rid67">67</a>]. Although phlegmasia involving the upper extremities is rare, a case series and report of 37 patients found that it commonly occurred in the setting of indwelling vascular catheters; concomitant lower extremity thrombosis was associated with worse outcomes [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Deep vein thrombolysis'</a> and  <a class="medical medical_review" href="/z/d/html/17036.html" rel="external">"Overview of thoracic central venous obstruction", section on 'Endovenous intervention'</a>.)</p><p>Catheter-directed thrombolysis with infusion of tissue plasminogen activator (tPA) over a 12- to 24-hour period has been used to manage such cases with reasonable success (50 to 90 percent clot lysis) but with an increased risk of bleeding (10 percent) [<a href="#rid77">77-79</a>]. In addition, pharmacomechanical thrombolysis with tPA infusion with or without angioplasty or stent placement of the affected vessel has been attempted for severe cases of central venous outflow obstruction [<a href="#rid80">80,81</a>]. (See  <a class="medical medical_review" href="/z/d/html/120732.html" rel="external">"Endovenous intervention for thoracic central venous obstruction"</a>.)</p><p>Percutaneous intervention followed by anticoagulation is associated with improved patency and a lowered incidence of post-thrombotic syndrome among patients with lower extremity DVT [<a href="#rid82">82</a>], but data regarding clinical outcomes in patients treated with this approach for PICC-related DVT do not exist.</p><p class="headingAnchor" id="H1812056377"><span class="h2">Handling the catheter</span><span class="headingEndMark"> — </span>As with other central venous catheters, routine PICC removal in the setting of DVT is <strong>not</strong> recommended. Rather, several factors should be considered in this respect, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Is the catheter clinically necessary? </p><p class="bulletIndent1"><span class="glyph">●</span>Is the PICC functional (that is, does it aspirate or infuse to achieve the intended clinical purpose)? </p><p class="bulletIndent1"><span class="glyph">●</span>Is the PICC tip centrally located? PICC tips that do not terminate at the cavoatrial junction or right atrium should be repositioned to ensure that the device is located in the ideal position. </p><p class="bulletIndent1"><span class="glyph">●</span>Is there a concern for infection associated with the catheter?</p><p></p><p>Resolution of thrombosis may be faster if the PICC is removed while anticoagulation is instituted; however, any desire to remove and reinsert the PICC in the contralateral upper extremity needs to weighed against the known high risk of recurrent thrombosis at the new site [<a href="#rid24">24,27</a>]. The risk of embolization of thrombus during catheter removal has not been well studied, but clinical practice suggests that overt embolization is low. An important exception is if the PICC is nonfunctional, as removal may help resolution of thrombosis and avoid complications such as bacteremia that may occur in the setting of thrombus [<a href="#rid83">83,84</a>]. Removal of the PICC should be considered if symptoms persist despite systemic anticoagulation or if thrombosis is associated with bacteremia [<a href="#rid67">67,85,86</a>]. </p><p class="headingAnchor" id="H282551198"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications of PICC-related deep vein thrombosis (DVT) can be classified as local versus systemic. </p><p>Local complications include phlebitis and inflammation of the affected vein ultimately leading to scarring and venous stenosis [<a href="#rid87">87,88</a>]. These changes have important implications for patients, especially those with chronic kidney disease; prior PICC placement is among the most important predictors of arteriovenous graft or fistula failure and threatens the success of dialysis in these individuals [<a href="#rid89">89,90</a>]. (See  <a class="medical medical_review" href="/z/d/html/17036.html" rel="external">"Overview of thoracic central venous obstruction", section on 'Etiologies'</a> and  <a class="medical medical_review" href="/z/d/html/1913.html" rel="external">"Central vein obstruction associated with upper extremity hemodialysis access", section on 'Mechanisms of obstruction'</a>.) </p><p>Although less frequent than in the lower extremities, pulmonary embolism may also occur with PICC-related DVT. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Embolization'</a>.)</p><p>Post-thrombotic syndrome, while infrequent, has also been described with PICC-related DVT and may lead to chronic pain, swelling, and/or extremity discoloration [<a href="#rid91">91</a>]. (See  <a class="medical medical_review" href="/z/d/html/8200.html" rel="external">"Post-thrombotic (postphlebitic) syndrome"</a>.)</p><p class="headingAnchor" id="H3051561440"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Like treatment, prevention of PICC-related deep vein thrombosis (DVT) includes the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Avoiding use of the PICC unless it is clinically appropriate or substituting a device associated with lower risk of thrombosis is a key strategy to prevent PICC-related DVT, especially given concerns for overuse of this device. Using published appropriateness criteria can assist with such decision making prior to PICC insertion [<a href="#rid92">92</a>]. Prospective studies examining implementation of appropriate use criteria across 50 Michigan hospitals demonstrated a reduction in PICC DVT with their use [<a href="#rid93">93</a>]. (See  <a class="medical medical_review" href="/z/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Michigan Appropriateness Guide for Intravenous Catheters (MAGIC)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the use of PICC is deemed appropriate, sizing the catheter properly relative to the target vein diameter and ensuring appropriate catheter tip location are important to minimize stasis vein and endothelial injury. (See <a class="local">'Device factors'</a> above and <a class="local">'Provider factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Removing devices promptly when they are no longer necessary is another important recommendation as most events occur within the first 7 to 14 days of dwell and accumulate over catheter dwell times [<a href="#rid27">27</a>]. Ensuring appropriate catheter tip location and sizing of catheter to veins to prevent stasis are also key prevention strategies. </p><p></p><p>Systemic use of venous thromboembolism prophylaxis (eg, subcutaneous heparin or low-molecular-weight heparin) is not associated with reduction in the risk of either centrally inserted venous catheter (CICC)- or PICC-related DVT. (See  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults", section on 'Prophylactic anticoagulation'</a>.)</p><p class="headingAnchor" id="H742144484"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113663.html" rel="external">"Society guideline links: Superficial vein thrombosis, deep vein thrombosis, and pulmonary embolism"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/117743.html" rel="external">"Society guideline links: Venous access"</a>.)</p><p class="headingAnchor" id="H3447248542"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon. </p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/693.html" rel="external">"Patient education: Deep vein thrombosis (DVT) (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/689.html" rel="external">"Patient education: Warfarin (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2444573016"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peripherally inserted central catheters</strong> – Peripherally inserted central catheter (PICC) use has become increasingly popular, but PICCs are associated with a greater risk for venous thrombosis (superficial and deep veins) compared with centrally inserted catheters. Some estimates suggest that PICCs are responsible for over one-third of all upper extremity deep vein thromboses (DVTs). (See <a class="local">'Incidence and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk for PICC-related DVT</strong> – Risk factors for DVT associated with PICC placement include prior DVT, obesity, recent surgery, malignancy, critical illness, presence of certain comorbidities (eg, diabetes, obstructive lung disease, obesity), use of multilumen catheters, lack of ultrasound use for PICC placement, malpositioned PICCs and guidewire exchange of PICCs. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms of thrombosis</strong> – Most catheter-related thromboses are clinically silent and usually occur in the first 7 to 14 days from the time of catheter placement. When symptoms do occur, patients typically complain of arm or forearm pain or swelling. The chest/upper extremity veins may dilate as collaterals develop to bypass the obstruction. (See <a class="local">'Clinical features and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of PICC-related DVT may be suspected clinically but must be confirmed with imaging that demonstrates venous thrombosis, typically using compression or duplex ultrasonography. Most PICC-related DVT occurs at the junction of the axillary and subclavian veins, but some also occur in isolated fashion in the vessels of the arm. Venography (computed tomography, catheter based) may be indicated if the diagnosis remains in question and clinical suspicion remains high. (See <a class="local">'Clinical features and diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – The treatment of PICC-related DVT is similar to that of other catheter-related DVT and consists of symptomatic care (extremity elevation, nonsteroidal anti-inflammatory drugs [NSAIDs]) and anticoagulation for a minimum of three months or longer if the catheter remains in place or if irreversible risk factors exist (eg, cancer). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The type and intensity of anticoagulation for catheter-related upper extremity DVT is similar to that given to prevent embolization from lower extremity DVT. (See <a class="local">'Anticoagulation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombolysis can be considered for selected patients (low risk, adequate life expectancy) with PICC-related DVT who have severe symptoms (&lt;14 days) that do not improve with anticoagulation and thrombosis spanning both the subclavian and axillary veins. (See <a class="local">'Thrombolysis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nonfunctional PICCs and those that are no longer clinically necessary should be removed, which may help resolution of thrombosis and avoid complications that may occur in the setting of thrombus (eg, bacteremia). (See <a class="local">'Handling the catheter'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For functioning PICCs that remain clinically necessary, routine removal in the setting of DVT is not recommended since reinsertion of a catheter in the contralateral upper extremity is associated with high risk of thrombosis. (See <a class="local">'Handling the catheter'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Phlebitis and inflammation of the affected upper extremity veins ultimately leads to scarring and venous stenosis. Such changes have important implications, particularly for patients with chronic kidney disease. Prior PICC placement is among the most important risk factors for hemodialysis arteriovenous vascular access failure, threatening the success of dialysis in these individuals. (See <a class="local">'Complications'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Prevention of PICC-related DVT includes (see <a class="local">'Prevention'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoiding use of the PICC unless it is clinically appropriate </p><p class="bulletIndent2"><span class="glyph">•</span>Ensuring appropriate catheter tip location </p><p class="bulletIndent2"><span class="glyph">•</span>Sizing of the catheter properly relative to the target vein diameter </p><p class="bulletIndent2"><span class="glyph">•</span>Removing devices promptly when they are no longer necessary </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Chopra V, Flanders SA, Saint S. The problem with peripherally inserted central catheters. JAMA 2012; 308:1527.</a></li><li><a class="nounderline abstract_t">Chemaly RF, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis 2002; 34:1179.</a></li><li><a class="nounderline abstract_t">Johansson E, Hammarskjöld F, Lundberg D, Arnlind MH. Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: a systematic review of the literature. Acta Oncol 2013; 52:886.</a></li><li><a class="nounderline abstract_t">Liem TK, Yanit KE, Moseley SE, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg 2012; 55:761.</a></li><li><a class="nounderline abstract_t">Malinoski D, Ewing T, Bhakta A, et al. Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit. J Trauma Acute Care Surg 2013; 74:454.</a></li><li><a class="nounderline abstract_t">Periard D, Monney P, Waeber G, et al. Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy. J Thromb Haemost 2008; 6:1281.</a></li><li><a class="nounderline abstract_t">Woller SC, Stevens SM, Jones JP, et al. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 2011; 124:947.</a></li><li><a class="nounderline abstract_t">Winters JP, Callas PW, Cushman M, et al. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study. J Thromb Haemost 2015; 13:2155.</a></li><li><a class="nounderline abstract_t">Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med 2011; 37:284.</a></li><li><a class="nounderline abstract_t">Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010; 138:803.</a></li><li><a class="nounderline abstract_t">Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9:312.</a></li><li><a class="nounderline abstract_t">Fallouh N, McGuirk HM, Flanders SA, Chopra V. Peripherally Inserted Central Catheter-associated Deep Vein Thrombosis: A Narrative Review. Am J Med 2015; 128:722.</a></li><li><a class="nounderline abstract_t">Nitta K, Yoneyama M. Polymer concentration dependence of the helix to random coil transition of a charged polypeptide in aqueous salt solution. Biophys Chem 1975; 3:323.</a></li><li><a class="nounderline abstract_t">Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013; 382:311.</a></li><li><a class="nounderline abstract_t">Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol 2000; 11:837.</a></li><li><a class="nounderline abstract_t">Patel GS, Jain K, Kumar R, et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer 2014; 22:121.</a></li><li><a class="nounderline abstract_t">Chopra V, Anand S, Krein SL, et al. Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence. Am J Med 2012; 125:733.</a></li><li><a class="nounderline abstract_t">Greene MT, Flanders SA, Woller SC, et al. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. Am J Med 2015; 128:986.</a></li><li><a class="nounderline abstract_t">Taxbro K, Hammarskjöld F, Thelin B, et al. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth 2019; 122:734.</a></li><li><a class="nounderline abstract_t">Kastora SL, Oduyoye O, Mahmood S. Upper extremity deep venous thrombosis prevalence in the NHS Grampian Medical Ambulatory clinic: diagnostic, therapeutic, and prognostic considerations in oncology patients. Ir J Med Sci 2022; 191:1569.</a></li><li><a class="nounderline abstract_t">Balsorano P, Virgili G, Villa G, et al. Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: A systematic review and meta-analysis. J Vasc Access 2020; 21:45.</a></li><li><a class="nounderline abstract_t">Chopra V, Ratz D, Kuhn L, et al. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost 2014; 12:847.</a></li><li><a class="nounderline abstract_t">King MM, Rasnake MS, Rodriguez RG, et al. Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J 2006; 99:1073.</a></li><li><a class="nounderline abstract_t">Chopra V, Kaatz S, Conlon A, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost 2017; 15:1951.</a></li><li><a class="nounderline abstract_t">Aw A, Carrier M, Koczerginski J, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res 2012; 130:323.</a></li><li><a class="nounderline abstract_t">Tran H, Arellano M, Chamsuddin A, et al. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma 2010; 51:1473.</a></li><li><a class="nounderline abstract_t">Chopra V, Fallouh N, McGuirk H, et al. Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study. Thromb Res 2015; 135:829.</a></li><li><a class="nounderline abstract_t">Martyak M, Kabir I, Britt R. Inpatient Peripherally Inserted Central Venous Catheter Complications: Should Peripherally Inserted Central Catheter Lines Be Placed in the Intensive Care Unit Setting? Am Surg 2017; 83:925.</a></li><li><a class="nounderline abstract_t">McAuliffe E, O'Shea S, Khan MI. PO-02 - Retrospective audit of the Peripherally Inserted Central Catheter (PICC) associated thrombosis in patients with haematological malignancies at Cork University Hospital. Thromb Res 2016; 140 Suppl 1:S176.</a></li><li><a class="nounderline abstract_t">Chen Y, Chen H, Yang J, et al. Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy. J Vasc Surg Venous Lymphat Disord 2020; 8:919.</a></li><li><a class="nounderline abstract_t">Jones D, Wismayer K, Bozas G, et al. The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients. Thromb J 2017; 15:25.</a></li><li><a class="nounderline abstract_t">Mitbander UB, Geer MJ, Taxbro K, et al. Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study. Cancer 2022; 128:3681.</a></li><li><a class="nounderline abstract_t">Marnejon T, Angelo D, Abu Abdou A, Gemmel D. Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J Vasc Access 2012; 13:231.</a></li><li><a class="nounderline abstract_t">Chopra V, Kaatz S, Grant P, et al. Risk of Venous Thromboembolism Following Peripherally Inserted Central Catheter Exchange: An Analysis of 23,000 Hospitalized Patients. Am J Med 2018; 131:651.</a></li><li><a class="nounderline abstract_t">Sharp R, Cummings M, Fielder A, et al. The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): a prospective cohort study. Int J Nurs Stud 2015; 52:677.</a></li><li><a class="nounderline abstract_t">Sharp R, Carr P, Childs J, et al. Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study. BMJ Open 2021; 11:e045895.</a></li><li><a class="nounderline abstract_t">Spencer TR, Mahoney KJ. Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio. J Thromb Thrombolysis 2017; 44:427.</a></li><li><a class="nounderline abstract_t">Sharp R, Cummings M, Childs J, et al. Measurement of Vein Diameter for Peripherally Inserted Central Catheter (PICC) Insertion: An Observational Study. J Infus Nurs 2015; 38:351.</a></li><li><a class="nounderline abstract_t">Saugel B, Scheeren TWL, Teboul JL. Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice. Crit Care 2017; 21:225.</a></li><li><a class="nounderline abstract_t">Trerotola SO, Stavropoulos SW, Mondschein JI, et al. Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology 2010; 256:312.</a></li><li><a class="nounderline abstract_t">O'Grady NP, Alexander M, Burns LA, et al. Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis 2011; 52:1087.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists Task Force on Central Venous Access, Rupp SM, Apfelbaum JL, et al. Practice guidelines for central venous access: a report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology 2012; 116:539.</a></li><li><a class="nounderline abstract_t">O'Brien J, Paquet F, Lindsay R, Valenti D. Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol 2013; 10:864.</a></li><li><a class="nounderline abstract_t">Swaminathan L, Flanders S, Rogers M, et al. Improving PICC use and outcomes in hospitalised patients: an interrupted time series study using MAGIC criteria. BMJ Qual Saf 2018; 27:271.</a></li><li><a class="nounderline abstract_t">Mermis JD, Strom JC, Greenwood JP, et al. Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. Ann Am Thorac Soc 2014; 11:1404.</a></li><li><a class="nounderline abstract_t">Ratz D, Hofer T, Flanders SA, et al. Limiting the Number of Lumens in Peripherally Inserted Central Catheters to Improve Outcomes and Reduce Cost: A Simulation Study. Infect Control Hosp Epidemiol 2016; 37:811.</a></li><li><a class="nounderline abstract_t">Li J, Fan YY, Xin MZ, et al. A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. Eur J Oncol Nurs 2014; 18:94.</a></li><li><a class="nounderline abstract_t">Katheria AC, Fleming SE, Kim JH. A randomized controlled trial of ultrasound-guided peripherally inserted central catheters compared with standard radiograph in neonates. J Perinatol 2013; 33:791.</a></li><li><a class="nounderline abstract_t">Vesely TM, Beathard G, Ash S, et al. A position statement from the American Society of Diagnostic and Interventional Nephrology. Semin Dial 2007; 20:359.</a></li><li><a class="nounderline abstract_t">Amerasekera SS, Jones CM, Patel R, Cleasby MJ. Imaging of the complications of peripherally inserted central venous catheters. Clin Radiol 2009; 64:832.</a></li><li><a class="nounderline abstract_t">Luciani A, Clement O, Halimi P, et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001; 220:655.</a></li><li><a class="nounderline abstract_t">Morden P, Sokhandon F, Miller L, et al. The role of saline flush injection rate in displacement of CT-injectable peripherally inserted central catheter tip during power injection of contrast material. AJR Am J Roentgenol 2014; 202:W13.</a></li><li><a class="nounderline abstract_t">Marcy PY, Guiffant G, Flaud P. Catheter tip displacements at power PICC CT injection. AJR Am J Roentgenol 2014; 203:W742.</a></li><li><a class="nounderline abstract_t">Baldinelli F, Capozzoli G, Pedrazzoli R, Marzano N. Evaluation of the correct position of peripherally inserted central catheters: anatomical landmark vs. electrocardiographic technique. J Vasc Access 2015; 16:394.</a></li><li><a class="nounderline abstract_t">Glauser F, Breault S, Rigamonti F, et al. Tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement. Eur Radiol 2017; 27:2843.</a></li><li><a class="nounderline abstract_t">Kleidon TM, Horowitz J, Rickard CM, et al. Peripherally Inserted Central Catheter Thrombosis After Placement via Electrocardiography vs Traditional Methods. Am J Med 2021; 134:e79.</a></li><li><a class="nounderline abstract_t">Constans J, Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99:202.</a></li><li><a class="nounderline abstract_t">Sakai H, Iwata M, Terasawa T. External validation of the Michigan PICC catheter-associated bloodstream infections score (MPC score) for predicting the risk of peripherally inserted central catheter-associated bloodstream infections: A single-center study in Japan. Infect Control Hosp Epidemiol 2023; 44:480.</a></li><li><a class="nounderline abstract_t">Kang J, Sun W, Li H, et al. Validation of Michigan risk score and D-dimer to predict peripherally inserted central catheter-related thrombosis: A study of 206,132 catheter days. J Vasc Access 2022; 23:764.</a></li><li><a class="nounderline abstract_t">Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost 2012; 108:1097.</a></li><li><a class="nounderline abstract_t">Maneval RE, Clemence BJ. Risk factors associated with catheter-related upper extremity deep vein thrombosis in patients with peripherally inserted central venous catheters: a prospective observational cohort study: part 2. J Infus Nurs 2014; 37:260.</a></li><li><a class="nounderline abstract_t">Seckold T, Walker S, Dwyer T. A comparison of silicone and polyurethane PICC lines and postinsertion complication rates: a systematic review. J Vasc Access 2015; 16:167.</a></li><li><a class="nounderline abstract_t">Pikwer A, Åkeson J, Lindgren S. Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia 2012; 67:65.</a></li><li><a class="nounderline abstract_t">Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e351S.</a></li><li><a class="nounderline abstract_t">Di Nisio M, Van Sluis GL, Bossuyt PM, et al. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8:684.</a></li><li><a class="nounderline abstract_t">Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160:e545.</a></li><li><a class="nounderline abstract_t">Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149:315.</a></li><li><a class="nounderline abstract_t">Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.</a></li><li><a class="nounderline abstract_t">Lee AY, Peterson EA, Wu C. Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology. Thromb Res 2016; 140 Suppl 1:S119.</a></li><li><a class="nounderline abstract_t">Fan F, Zou Y, Zhang S, et al. Rivaroxaban in the Treatment of PICC-associated Upper Extremity Venous Thrombosis. Clin Ther 2017; 39:1882.</a></li><li><a class="nounderline abstract_t">Athanazio RA, Ceresetto JM, Marfil Rivera LJ, et al. Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective. Clin Appl Thromb Hemost 2022; 28:10760296221082988.</a></li><li><a class="nounderline abstract_t">Khorana AA, Mackman N, Falanga A, et al. Cancer-associated venous thromboembolism. Nat Rev Dis Primers 2022; 8:11.</a></li><li><a class="nounderline abstract_t">Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol 2021; 28:5434.</a></li><li><a class="nounderline abstract_t">Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013; 31:1357.</a></li><li><a class="nounderline abstract_t">Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013; 11:71.</a></li><li><a class="nounderline abstract_t">Greenberg J, Troutman DA, Shubinets V, et al. Phlegmasia Cerulea Dolens in the Upper Extremity: A Case Report and Systematic Review and Outcomes Analysis. Vasc Endovascular Surg 2016; 50:98.</a></li><li><a class="nounderline abstract_t">Vik A, Holme PA, Singh K, et al. Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities. Cardiovasc Intervent Radiol 2009; 32:980.</a></li><li><a class="nounderline abstract_t">Vedantham S, Piazza G, Sista AK, Goldenberg NA. Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism. J Thromb Thrombolysis 2016; 41:68.</a></li><li><a class="nounderline abstract_t">Maleux G, Marchal P, Palmers M, et al. Catheter-directed thrombolytic therapy for thoracic deep vein thrombosis is safe and effective in selected patients with and without cancer. Eur Radiol 2010; 20:2293.</a></li><li><a class="nounderline abstract_t">Ozcinar E, Yaman ND, Cakici M, et al. Pharmacomechanical thrombectomy of upper extremity deep vein thrombosis. Int Angiol 2017; 36:275.</a></li><li><a class="nounderline abstract_t">van den Houten MM, van Grinsven R, Pouwels S, et al. Treatment of upper-extremity outflow thrombosis. Phlebology 2016; 31:28.</a></li><li><a class="nounderline abstract_t">Wang CN, Deng HR. Percutaneous Endovenous Intervention Plus Anticoagulation versus Anticoagulation Alone for Treating Patients with Proximal Deep Vein Thrombosis: A Meta-analysis and Systematic Review. Ann Vasc Surg 2018; 49:39.</a></li><li><a class="nounderline abstract_t">Menéndez JJ, Verdú C, Calderón B, et al. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children. J Thromb Haemost 2016; 14:2158.</a></li><li><a class="nounderline abstract_t">Del Principe MI, Buccisano F, Maurillo L, et al. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. Thromb Res 2013; 132:511.</a></li><li><a class="nounderline abstract_t">Sousa B, Furlanetto J, Hutka M, et al. Central venous access in oncology: ESMO Clinical Practice Guidelines. Ann Oncol 2015; 26 Suppl 5:v152.</a></li><li><a class="nounderline abstract_t">Stevens SM, Woller SC, Baumann Kreuziger L, et al. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160:2247.</a></li><li><a class="nounderline abstract_t">Shin HS, Towbin AJ, Zhang B, et al. Venous thrombosis and stenosis after peripherally inserted central catheter placement in children. Pediatr Radiol 2017; 47:1670.</a></li><li><a class="nounderline abstract_t">Gonsalves CF, Eschelman DJ, Sullivan KL, et al. Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement. Cardiovasc Intervent Radiol 2003; 26:123.</a></li><li><a class="nounderline abstract_t">El Ters M, Schears GJ, Taler SJ, et al. Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis 2012; 60:601.</a></li><li><a class="nounderline abstract_t">McGill RL, Tsukahara T, Bhardwaj R, et al. Inpatient venous access practices: PICC culture and the kidney patient. J Vasc Access 2015; 16:206.</a></li><li><a class="nounderline abstract_t">Ong B, Gibbs H, Catchpole I, et al. Peripherally inserted central catheters and upper extremity deep vein thrombosis. Australas Radiol 2006; 50:451.</a></li><li><a class="nounderline abstract_t">Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med 2015; 163:S1.</a></li><li><a class="nounderline abstract_t">Chopra V, O'Malley M, Horowitz J, et al. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ Qual Saf 2022; 31:23.</a></li></ol></div><div id="topicVersionRevision">Topic 116371 Version 13.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23073947" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The problem with peripherally inserted central catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11941543" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23472835" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Advantages and disadvantages of peripherally inserted central venous catheters (PICC) compared to other central venous lines: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22370026" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23354238" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18541001" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21962315" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26340226" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20857280" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20923799" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Risk of symptomatic DVT associated with peripherally inserted central catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21040443" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25697969" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Peripherally Inserted Central Catheter-associated Deep Vein Thrombosis: A Narrative Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/96" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Polymer concentration dependence of the helix to random coil transition of a charged polypeptide in aqueous salt solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23697825" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10928518" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Venous thrombosis related to peripherally inserted central catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24005884" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22840660" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Bloodstream infection, venous thrombosis, and peripherally inserted central catheters: reappraising the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25940453" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31005243" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34515987" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Upper extremity deep venous thrombosis prevalence in the NHS Grampian Medical Ambulatory clinic: diagnostic, therapeutic, and prognostic considerations in oncology patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31177939" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24612469" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17100027" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28796444" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22444157" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20443681" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25726426" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28822403" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Inpatient Peripherally Inserted Central Venous Catheter Complications: Should Peripherally Inserted Central Catheter Lines Be Placed in the Intensive Care Unit Setting?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161689" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : PO-02 - Retrospective audit of the Peripherally Inserted Central Catheter (PICC) associated thrombosis in patients with haematological malignancies at Cork University Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32205131" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Patterns and risk factors of peripherally inserted central venous catheter-related symptomatic thrombosis events in patients with malignant tumors receiving chemotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28936124" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35943390" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22266584" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29408616" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Risk of Venous Thromboembolism Following Peripherally Inserted Central Catheter Exchange: An Analysis of 23,000 Hospitalized Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25593110" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34226216" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29022210" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26339941" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Measurement of Vein Diameter for Peripherally Inserted Central Catheter (PICC) Insertion: An Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28844205" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20574104" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21467014" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22307320" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Practice guidelines for central venous access: a report by the American Society of Anesthesiologists Task Force on Central Venous Access.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24075218" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Insertion of PICCs with minimum number of lumens reduces complications and costs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29133462" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Improving PICC use and outcomes in hospitalised patients: an interrupted time series study using MAGIC criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25295962" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27033138" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Limiting the Number of Lumens in Peripherally Inserted Central Catheters to Improve Outcomes and Reduce Cost: A Simulation Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24018351" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23765173" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A randomized controlled trial of ultrasound-guided peripherally inserted central catheters compared with standard radiograph in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17635830" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A position statement from the American Society of Diagnostic and Interventional Nephrology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19589422" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Imaging of the complications of peripherally inserted central venous catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11526263" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24370160" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The role of saline flush injection rate in displacement of CT-injectable peripherally inserted central catheter tip during power injection of contrast material.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25415742" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Catheter tip displacements at power PICC CT injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26109544" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Evaluation of the correct position of peripherally inserted central catheters: anatomical landmark vs. electrocardiographic technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27957644" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32673624" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Peripherally Inserted Central Catheter Thrombosis After Placement via Electrocardiography vs Traditional Methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18217155" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A clinical prediction score for upper extremity deep venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34924068" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : External validation of the Michigan PICC catheter-associated bloodstream infections score (MPC score) for predicting the risk of peripherally inserted central catheter-associated bloodstream infections: A single-center study in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33860712" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Validation of Michigan risk score and D-dimer to predict peripherally inserted central catheter-related thrombosis: A study of 206,132 catheter days.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23093319" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Diagnosis and management of upper extremity deep-vein thrombosis in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24983259" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Risk factors associated with catheter-related upper extremity deep vein thrombosis in patients with peripherally inserted central venous catheters: a prospective observational cohort study: part 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25634150" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : A comparison of silicone and polyurethane PICC lines and postinsertion complication rates: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21972789" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Complications associated with peripheral or central routes for central venous cannulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315267" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20141579" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34352278" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26867832" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315268" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27067964" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Clinical practice guidelines on cancer-associated thrombosis: a review on scope and methodology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28823518" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Rivaroxaban in the Treatment of PICC-associated Upper Extremity Venous Thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35261295" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism: A Latin American Perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35177631" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Cancer-associated venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34940092" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23460705" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23217208" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26912398" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Phlegmasia Cerulea Dolens in the Upper Extremity: A Case Report and Systematic Review and Outcomes Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19641959" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Catheter-directed thrombolysis for treatment of deep venous thrombosis in the upper extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26780739" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20349241" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Catheter-directed thrombolytic therapy for thoracic deep vein thrombosis is safe and effective in selected patients with and without cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27603199" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pharmacomechanical thrombectomy of upper extremity deep vein thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26916766" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Treatment of upper-extremity outflow thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29454036" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Percutaneous Endovenous Intervention Plus Anticoagulation versus Anticoagulation Alone for Treating Patients with Proximal Deep Vein Thrombosis: A Meta-analysis and Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27558946" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24090605" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26314776" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Central venous access in oncology: ESMO Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34352279" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28685192" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Venous thrombosis and stenosis after peripherally inserted central catheter placement in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12616419" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22704142" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25634154" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Inpatient venous access practices: PICC culture and the kidney patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16981942" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Peripherally inserted central catheters and upper extremity deep vein thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26369828" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33782091" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
